Skip to content
Medical Health Aged Care

Arthritis Australia Expert Summit (Federal Parliament House)

Arthritis Australia 2 mins read

 

Access to physios and dietitians essential to address escalating arthritis crisis

 

  • Representatives of the arthritis community and leading experts will gather in Parliament House for the first time to address the escalating issues in arthritis and musculoskeletal care.
  • Arthritis Australia is calling for affordable, non-surgical care from physiotherapists, dietitians, and other allied health professionals to help stem the escalating arthritis crisis placing unprecedented strain on our communities, hospitals, and health budget.
  • More than a third of Australians are living with arthritis and musculoskeletal conditions, including back pain. Together they are our most costly disease group with an annual burden of $15 billion.1
  • Hip and knee replacements for osteoarthritis have reached a record high, averaging over 370 procedures per day and projected to more than double by 2030 to an unsustainable over 650 daily surgeries. 2,3,4
  • Research shows education and support for exercise, weight loss, and pain management through allied health professionals can reduce costly hip and knee replacements by a third - saving $1.01 billion annually.5

Available for interviews:

  • Professor David Hunter – Florance and Cope Chair of Rheumatology, Co-Director Sydney Musculoskeletal Health Flagship, University of Sydney
  • Jonathan Smithers – CEO, Arthritis Australia
  • Representatives of the arthritis community

 

Details:

Location: Private Dining Room, Parliament House Canberra

Date & Time: Thursday 22nd August 2024, 9.30am – 1.00pm

 

 

References

  1. Australian Institute of Health and Welfare (2023) Health system spending on disease and injury in Australia, 2020-21, AIHW, Australian Government, accessed 25 January 2024.
  2. Ackerman I et. al., (2019). The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. Accessed 13 August 2024
  3. Australian Orthopaedic Association National Joint Replacement Registry, Procedures Reported (hip and knee). Accessed at https://aoanjrr.sahmri.com/procedures-reported.
  4. Ackerman, I.N., Bohensky, M.A., Zomer, E. et al. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord 20, 90 (2019). https://doi.org/10.1186/s12891-019-2411-9
  5. Ackerman IN, Skou ST, Roos EM, Barton CJ, Kemp JL, Crossley KM, Liew D, Ademi Z. Implementing a national first-line management program for moderate-severe knee osteoarthritis in Australia: A budget impact analysis focusing on knee replacement avoidance. Osteoarthr Cartil Open. 2020 May 6;2(3):100070. doi: 10.1016/j.ocarto.2020.100070. PMID: 36474677; PMCID: PMC9718332

 


About us:

About Arthritis Australia

Arthritis Australia is the peak national body for arthritis, advocating on behalf of over 4 million Australians living with arthritis, and working with many other arthritis organisations to deliver information and support to people living with more than 100 types of arthritis and musculoskeletal conditions. We are a leading non-government funder of arthritis research in Australia and advocate for policies, programs and funding initiatives that will improve the health and wellbeing of people living with arthritis. For more information visit: arthritisaustralia.com.au


Contact details:

ssued by Cube on behalf of Arthritis Australia. For more information, please contact: Anne-Marie Sparrow on 0417 421 560 or Kayla Behayi on 0403 425 572.

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.